An European patent titled “USE OF FLAVONOID COMPOUND IN PREPARATION OF COMPOSITION FOR HEALING WOUND” has been granted.

Published Date:2023-11-29

Statement
No	1	Date of announcement	2023/11/29	Time of announcement	17:01:08
Subject	An European patent titled “USE OF FLAVONOID COMPOUND IN PREPARATION OF COMPOSITION FOR HEALING WOUND” has been granted.
To which item it meets	paragraph 53			Date of events	2023/11/29
Date of occurrence of the event:2023/11/29 Company name:ONENESS BIOTECH CO., LTD. Relationship to the Company (please enter “head office” or “subsidiaries”):head office Reciprocal shareholding ratios:NA Cause of occurrence:The Company has been informed by the patent agency that an European patent titled “USE OF FLAVONOID COMPOUND IN PREPARATION OF COMPOSITION FOR HEALING WOUND” has been granted under the patent number EP3189837. Countermeasures:None Any other matters that need to be specified(the information disclosure also meets the requirements of Article 7, subparagraph 9 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.): This patent is to protect the active compound in Fespixon cream (Research code: ON101), which is part of global patent protection of Fespixon cream. No manufacturing of the active compound of Plectranthus amboinicus will be allowed.